MAPflow Blog
Partnership announcements, awards, and media coverage.
One year in, PEI pharmacies have logged 1,000+ clinical assessments and a 96.7% resolution rate through the PEIPhA–MAPflow partnership. Members can now continue at the deepest discount MAPflow has ever offered an association partner in Canada.
MAPflow Inc. has announced a strategic partnership with the Pharmacists’ Association of Newfoundland & Labrador (PANL) to expand access to its clinical workflow platform across the province. The collaboration provides PANL members with exclusive pricing and access to tools supporting minor ailment assessments, prescribing workflows, documentation, and chronic disease management. The partnership is designed to strengthen clinical practice, reduce administrative and audit burden, and leverage anonymized data insights to support advocacy and demonstrate the impact of pharmacy services across Newfoundland & Labrador.
Pharmacists Manitoba has partnered with MAPflow to provide members with access to a pharmacist-designed clinical workflow platform that supports assessment, prescribing for self-limiting conditions, OTC consultations, and chronic disease management. The partnership includes exclusive member pricing, training, onboarding, and support, helping pharmacists improve efficiency, enhance patient care, and strengthen advocacy through real-world usage insights.
The Prince Edward Island Pharmacists' Association (PEIPhA) is proud to announce an exciting new partnership with MAPflow that will revolutionize how Island pharmacy teams deliver healthcare services.
New Brunswick Pharmacists’ Association (NBPA) is pleased to announce a newly established partnership with MAPflow, available exclusively to Association members.
Pharmacists providing minor ailment assessment and prescribing services now have the connection of two powerful resources, MAPflow and Canadian Pharmacists Association (CPhA), in their toolkit.
MAPflow launches in BC as a new software tool to aid pharmacists in assessing and prescribing minor ailments.